IL127464A0 - Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders - Google Patents
Piperidine acetic acid derivatives and their use in the treatment of thrombotic disordersInfo
- Publication number
- IL127464A0 IL127464A0 IL12746497A IL12746497A IL127464A0 IL 127464 A0 IL127464 A0 IL 127464A0 IL 12746497 A IL12746497 A IL 12746497A IL 12746497 A IL12746497 A IL 12746497A IL 127464 A0 IL127464 A0 IL 127464A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- acetic acid
- acid derivatives
- thrombotic disorders
- piperidine acetic
- Prior art date
Links
- 208000007536 Thrombosis Diseases 0.000 title 1
- RAIYODFGMLZUDF-UHFFFAOYSA-N piperidin-1-ium;acetate Chemical class CC([O-])=O.C1CC[NH2+]CC1 RAIYODFGMLZUDF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9613095.0A GB9613095D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic piperidines |
| GBGB9613017.4A GB9613017D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic compounds |
| GBGB9613018.2A GB9613018D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic indazoles |
| PCT/EP1997/003196 WO1997049699A1 (en) | 1996-06-21 | 1997-06-19 | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL127464A0 true IL127464A0 (en) | 1999-10-28 |
Family
ID=27268341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12746497A IL127464A0 (en) | 1996-06-21 | 1997-06-19 | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0912555A1 (cs) |
| JP (1) | JP2000512648A (cs) |
| KR (1) | KR20000022041A (cs) |
| AP (1) | AP9801417A0 (cs) |
| AR (1) | AR008245A1 (cs) |
| AU (1) | AU3261197A (cs) |
| BR (1) | BR9709930A (cs) |
| CA (1) | CA2258753A1 (cs) |
| CZ (1) | CZ424698A3 (cs) |
| EA (1) | EA199801015A1 (cs) |
| ID (1) | ID17052A (cs) |
| IL (1) | IL127464A0 (cs) |
| IS (1) | IS4924A (cs) |
| NO (1) | NO985974L (cs) |
| PL (1) | PL330797A1 (cs) |
| TR (1) | TR199802665T2 (cs) |
| WO (1) | WO1997049699A1 (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7064215B2 (en) | 2001-07-03 | 2006-06-20 | Chiron Corporation | Indazole benzimidazole compounds |
| US7642278B2 (en) | 2001-07-03 | 2010-01-05 | Novartis Vaccines And Diagnostics, Inc. | Indazole benzimidazole compounds |
| TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| AU2004213374A1 (en) | 2003-02-14 | 2004-09-02 | Wyeth | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| CN101432274A (zh) | 2006-04-05 | 2009-05-13 | 惠氏公司 | 作为5-羟色胺-6配体的磺酰基-3-杂环吲唑衍生物 |
| BRPI0806542A2 (pt) | 2007-01-10 | 2014-04-22 | Hoffmann La Roche | Derivados de sulfonamida como inibidores de quimase |
| CN113655155A (zh) * | 2021-07-28 | 2021-11-16 | 任贤金 | 一种测定sph3127有关物质的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| WO1993010091A2 (en) * | 1991-11-14 | 1993-05-27 | Glaxo Group Limited | Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
| GB9208740D0 (en) * | 1992-04-23 | 1992-06-10 | Glaxo Group Ltd | Chemical compounds |
-
1997
- 1997-06-18 AR ARP970102676A patent/AR008245A1/es unknown
- 1997-06-19 TR TR1998/02665T patent/TR199802665T2/xx unknown
- 1997-06-19 AU AU32611/97A patent/AU3261197A/en not_active Abandoned
- 1997-06-19 CZ CZ984246A patent/CZ424698A3/cs unknown
- 1997-06-19 CA CA002258753A patent/CA2258753A1/en not_active Abandoned
- 1997-06-19 EP EP97928243A patent/EP0912555A1/en not_active Withdrawn
- 1997-06-19 WO PCT/EP1997/003196 patent/WO1997049699A1/en not_active Ceased
- 1997-06-19 BR BR9709930A patent/BR9709930A/pt not_active Application Discontinuation
- 1997-06-19 PL PL97330797A patent/PL330797A1/xx unknown
- 1997-06-19 JP JP10502284A patent/JP2000512648A/ja active Pending
- 1997-06-19 IL IL12746497A patent/IL127464A0/xx unknown
- 1997-06-19 EA EA199801015A patent/EA199801015A1/ru unknown
- 1997-06-19 KR KR1019980710439A patent/KR20000022041A/ko not_active Withdrawn
- 1997-06-19 ID IDP972092A patent/ID17052A/id unknown
- 1997-06-19 AP APAP/P/1998/001417A patent/AP9801417A0/en unknown
-
1998
- 1998-12-15 IS IS4924A patent/IS4924A/is unknown
- 1998-12-18 NO NO985974A patent/NO985974L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000022041A (ko) | 2000-04-25 |
| JP2000512648A (ja) | 2000-09-26 |
| IS4924A (is) | 1998-12-15 |
| NO985974L (no) | 1999-02-17 |
| EP0912555A1 (en) | 1999-05-06 |
| NO985974D0 (no) | 1998-12-18 |
| CZ424698A3 (cs) | 1999-05-12 |
| CA2258753A1 (en) | 1997-12-31 |
| AR008245A1 (es) | 1999-12-29 |
| ID17052A (id) | 1997-12-04 |
| BR9709930A (pt) | 1999-08-10 |
| AP9801417A0 (en) | 1998-12-31 |
| AU3261197A (en) | 1998-01-14 |
| TR199802665T2 (xx) | 1999-03-22 |
| EA199801015A1 (ru) | 1999-08-26 |
| PL330797A1 (en) | 1999-06-07 |
| WO1997049699A1 (en) | 1997-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3339897A (en) | Sulphonamide derivatives and their use in the treatment of cns disorders | |
| GR980300033T1 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| IL126900A0 (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
| AU3725997A (en) | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders | |
| PL327610A1 (en) | Quinoline and quinozoline compounds useful in therapy | |
| AU4171500A (en) | Flupirtine in the treatment of fibromyalgia and related conditions | |
| AU6566094A (en) | Heterocyclic derivatives in the treatment of ischaemia and related diseases | |
| ZA979175B (en) | Novel piperidineketocarboxylic acid derivatives their preparation and use | |
| AU4342989A (en) | Mercapto-acylamino acids useful in the treatment of cardiovascular disorders and as analgesics | |
| HUP0102781A3 (en) | Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies | |
| ZA973097B (en) | Novel aspire-hydroxy acid derivatives their preparation and use | |
| AU3099997A (en) | The use of tcet in the prophylaxis and treatment of allergies | |
| GB9507415D0 (en) | Production and uses of caffeic acid and derivatives thereof | |
| AU3268197A (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
| IL126027A0 (en) | Novel carboxylic acid derivatives their preparation and use | |
| AU3261097A (en) | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders | |
| ZA973096B (en) | Novel carboxylic acid derivatives their preparation and use | |
| GB9624658D0 (en) | Improvements in or relating to the monitoring of people | |
| IL127464A0 (en) | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders | |
| IL131666A0 (en) | Novel carboxylic acid derivatives their preparation and use in treating cancer | |
| AU3114295A (en) | Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases | |
| FI954138L (fi) | Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä | |
| AU4569993A (en) | Bile acid derivative and use thereof in therapy | |
| AU2705495A (en) | Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory | |
| EP0893123A4 (en) | MEANS OF PREVENTIVE AND CURATIVE TREATMENT OF CONDITIONS RELATED TO DIFFERENT FORMS OF AGING OF THE ORGANISM |